Taipei, Taiwan

Jiann-Shiun Lai

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2018-2024

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Inspiring Innovations: The Legacy of Jiann-Shiun Lai

Introduction:

Jiann-Shiun Lai, a remarkable inventor hailing from Taipei, Taiwan, has captivated the world with his passion for innovation and unwavering commitment to excellence. His trailblazing inventions have significantly shaped the landscape of technology and industries on a global scale.

Latest Patents:

With an impressive portfolio of 9 patents to his name, Jiann-Shiun Lai's latest patents are revolutionizing the field of pharmaceutical compositions and antibody-based therapies. These patents focus on antibodies or antigen binding fragments that target specific cancer cell surfaces, offering novel methods for cancer therapies and diagnostics across an array of carcinoma types.

Career Highlights:

As a key figure at Obi Pharma Inc., Jiann-Shiun Lai has spearheaded groundbreaking research and development efforts in the healthcare industry. His expertise in developing cutting-edge pharmaceutical compositions has not only advanced the field but also provided hope for patients battling various forms of cancer.

Collaborations:

Collaborating closely with esteemed coworkers such as I-Ju Chen and Cheng-Der Tony Yu, Jiann-Shiun Lai has fostered a culture of innovation and collaboration within his workplace. Together, they have synergized their talents to bring forth novel solutions that have the potential to transform cancer treatment paradigms.

Conclusion:

Jiann-Shiun Lai's indelible mark on the world of technology and healthcare stands as a testament to his visionary spirit and relentless pursuit of excellence. His inventions continue to inspire aspiring inventors and pave the way for a brighter, more innovative future in the realm of cancer therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…